Not only in CNS, the TLR4 signaling pathway may also be the primary cause of activated inflammation in the cardiovascular system of MPS I and VII patients [178,179] as well as in the osteoarticular system of patients with MPS I, II, VI, and VII [180]. Here, TLR4 is linked to Scheie syndrome.